Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference
- PMID: 30602169
- DOI: 10.1159/000493386
Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference
Abstract
Amyotrophic lateral sclerosis (ALS) epidemiology has rapidly developed in the last 30 years alongside the evolving changes in concepts in the field of clinical ALS and also due to the recent proposals of new classification system for motor neuron diseases. Many of these changes in the clinical scenario have been determined through the results of ALS population-based studies conducted in the last 20 years primarily in Europe. All the evidences converge to show that ALS risk is different across continents and ethnicities. In a European registry consortium named EURALS, ALS incident cases were drawn from a source population comprising almost 24 million people across Europe (ALS cases: 1028) and the estimated incidence was 2.2 per 100,000 person-years (py) for the general population. In contrast, other population-based studies have measured the lowest incidence in East Asia to be 0.89 per 100,000 py and in South Asia to be 0.79 per 100,000 py. A large part of Africa, Latin America and Asia does not have any population-based studies. The origin of geographic difference in ALS incidence is a matter of debate. Probably, this is partly due to genes (C9ORF72) and partly due to environmental risk factors. The rapid disappearance of ALS Foci in Guam, Kii, and West Guinea underline the importance of changes in lifestyle and environmental factors. The Global Burden of Disease, a project aiming to describe the burden of all diseases and injuries across all the countries of the world with a standardized protocol, has collected heterogeneous sources of data to estimate the burden of motor neuron diseases. The demographic changes related to increased expectation of life and the growth of the world population indicate that the load of motor neuron disease is rapidly moving toward 400 thousand prevalent cases. The burden is expected to shift toward Asia and Africa in the next decades for the rapid increase of expectation of life of countries with high demographic impact.
Keywords: Amyotrophic lateral sclerosis; Ancestry; C9ORF72; Cohort; Ethnicity; Geographic gradient; Global Burden of Disease; Incidence; Population-based study; Registries.
© 2019 S. Karger AG, Basel.
Similar articles
-
Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.Neuroepidemiology. 2021;55(5):342-353. doi: 10.1159/000516752. Epub 2021 Jul 9. Neuroepidemiology. 2021. PMID: 34247168 Review.
-
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.MMWR Surveill Summ. 2016 Aug 5;65(8):1-12. doi: 10.15585/mmwr.ss6508a1. MMWR Surveill Summ. 2016. PMID: 27490513
-
[Disappearance of ALS from Guam: implications for exogenous causes].Rinsho Shinkeigaku. 1995 Dec;35(12):1549-53. Rinsho Shinkeigaku. 1995. PMID: 8752460 Review. Japanese.
-
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.MMWR Suppl. 2014 Jul 25;63(7):1-14. MMWR Suppl. 2014. PMID: 25054277
-
Epidemiological and genetic features of amyotrophic lateral sclerosis in Latin America and the Caribbean: a systematic review.Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):4-15. doi: 10.1080/21678421.2021.1909066. Epub 2021 Apr 19. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 33871294
Cited by
-
Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States.Mayo Clin Proc Innov Qual Outcomes. 2024 Sep 17;8(5):482-492. doi: 10.1016/j.mayocpiqo.2024.07.008. eCollection 2024 Oct. Mayo Clin Proc Innov Qual Outcomes. 2024. PMID: 39323877 Free PMC article.
-
Behavioral variant frontotemporal dementia in patients with primary psychiatric disorder: A magnetic resonance imaging study.Brain Behav. 2023 Apr;13(4):e2896. doi: 10.1002/brb3.2896. Epub 2023 Mar 2. Brain Behav. 2023. PMID: 36864745 Free PMC article.
-
Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration.Int J Mol Sci. 2024 May 21;25(11):5587. doi: 10.3390/ijms25115587. Int J Mol Sci. 2024. PMID: 38891774 Free PMC article. Review.
-
Use of a modular ontology and a semantic annotation tool to describe the care pathway of patients with amyotrophic lateral sclerosis in a coordination network.PLoS One. 2021 Jan 6;16(1):e0244604. doi: 10.1371/journal.pone.0244604. eCollection 2021. PLoS One. 2021. PMID: 33406098 Free PMC article.
-
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies.Pharmaceuticals (Basel). 2024 Oct 18;17(10):1391. doi: 10.3390/ph17101391. Pharmaceuticals (Basel). 2024. PMID: 39459030 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous